Skip to main content
. 2020 Mar 20;15(3):e0230273. doi: 10.1371/journal.pone.0230273

Table 4. Comparisons of sleep characteristics between the RLS and non-RLS groups.

RLS (n = 10) Non-RLS (n = 60) p-value
PSQI
    Global score, median (IQR) 8.0 (4.0–14.0) 5.5 (4.0–9.0) 0.16
    Global score ≥6, n (%) 6 (60) 30 (50) 0.56
    PSQI components, n (%)
        C1: subjective sleep quality ≥2 3 (30) 14 (23) 0.64
        C2: sleep latency ≥2* 4 (40) 15 (25) 0.32
        C3: sleep duration ≥2** 8 (80) 19 (32) 0.004
        C4: habitual sleep efficiency ≥2*** 1 (10) 4 (6.7) 0.71
        C5: sleep disturbances ≥2 7 (70) 37 (62) 0.61
        C6: use of sleeping medication ≥2**** 2 (20) 12 (20) 1.00
        C7: daytime dysfunction ≥2 1 (10) 3 (5.0) 0.53
ISS, median (IQR) 5.5(3.0–8.5) 4.0 (2.0–6.0) 0.25
    ISS ≥10, n (%) 2 (20.0) 8 (13.3) 0.63
Symptoms of insomnia, n (%)
    Difficulty initiating sleep 7 (70) 23 (38) 0.06
    Difficulty maintaining sleep 4 (40) 24 (40) 1.00
    Waking up too early 1 (10) 19 (31) 0.16
Any symptoms, mild to very severe 7 (70) 31 (52) 0.28
ESS, median (IQR) 5.0 (3.25–7.75) 5.0 (3.00–8.75) 0.93
ESS ≥10, n (%) 2 (20.0) 11 (18.3) 1.00

*Sleep latency ≥31 min and the presence of difficulty initiating sleep.

**Total sleep time <6 hr.

***Sleep efficiency <85%.

**** >1 time. P-values were determined by nonparametric Wilcoxon rank sum test and Fisher's exact test. ESS: Epworth Sleepiness Scale, ISS: Insomnia Severity Index, PSQI: Pittsburgh Sleep Quality Index.